Broad Discovery Series: The story behind a new therapy for lung cancer patients
By
Broad Institute of MIT and Harvard
Free
Heidi Greulich and Matthew Meyerson will describe the 20-year history of sevabertinib, a new lung cancer drug that blocks both EGFR and the related HER2 protein.
Sign-up Information
- Ages: Adults.
Registration required
- Sign-up is ongoing
Cost
This Event is free!
ቦታ
- Both in-person and virtual (online or over the phone).
415 Main Street
Cambridge, MA 02142
ዩናይትድ ስቴትስ
Neighborhood
Dates and Times
ማክሰኞ, February 24 6PM – 8PM
Free
Share with your friends!
Images (1)
Is there anything wrong or outdated? Please let Find It Cambridge know!
Last updated February 4, 2026.
See all events from Broad Institute of MIT and Harvard
See all programs from Broad Institute of MIT and Harvard